APA (7th ed.) Citation

MJR, D., JL, M., P, W., A, A. J., T, S., N, K., . . . AP, B. (2026). Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent. Haematologica, 111(7), 2494. https://doi.org/10.3324/haematol.2025.289179

Chicago Style (17th ed.) Citation

MJR, Desborough, et al. "Recombinant Von Willebrand Factor (vonicog Alfa) Reduces Platelet Inhibition Caused by Antiplatelet Drugs and Has Potential as an Acute Haemostatic Agent." Haematologica 111, no. 7 (2026): 2494. https://doi.org/10.3324/haematol.2025.289179.

MLA (9th ed.) Citation

MJR, Desborough, et al. "Recombinant Von Willebrand Factor (vonicog Alfa) Reduces Platelet Inhibition Caused by Antiplatelet Drugs and Has Potential as an Acute Haemostatic Agent." Haematologica, vol. 111, no. 7, 2026, p. 2494, https://doi.org/10.3324/haematol.2025.289179.